phosphatidylcholines has been researched along with monodansylcadaverine in 2 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (monodansylcadaverine) | Trials (monodansylcadaverine) | Recent Studies (post-2010) (monodansylcadaverine) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 402 | 0 | 60 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mato, JM; Pastan, I; Pencev, D; Schiffmann, E; Vasanthakumar, G | 1 |
Garcia Gil, M; Sanchez Crespo, M | 1 |
2 other study(ies) available for phosphatidylcholines and monodansylcadaverine
Article | Year |
---|---|
Inhibitors of endocytosis perturb phospholipid metabolism in rabbit neutrophils and other cells.
Topics: Animals; Cadaverine; Chemotaxis, Leukocyte; Choline; Diamines; Endocytosis; Membrane Lipids; Neutrophils; Phosphatidylcholines; Phospholipids; Rabbits | 1983 |
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes.
Topics: Adamantane; Amantadine; Antineoplastic Agents; Cadaverine; Diamines; Humans; Neutrophils; Phagocytosis; Phosphatidylcholines; Platelet Activating Factor; Rimantadine | 1983 |